In a novel lab environment using mini kidney structures, drugs blocked the swelling of tubes seen with polycystic kidney disease.
Harnessing light energy to rejuvenate mitochondrial membrane potential slowed aging in C. elegans.
Most Alzheimer’s drugs in development target beta-amyloid, but targeting another protein, called tau, may be needed.
Premera Blue Cross invests $6.6 million in UW fellowship to help address state's mental-health workforce crisis.
Latest work unexpectedly shows two close bat virus relatives of human respiratory virus MERS-CoV use bat ACE2 as cell entry receptor.
The advance creates hope for treating glaucoma and other neurodegenerative conditions in humans.
The agreement opens more opportunities for medical students to learn how to care for Native American peoples.
Results from a new molecular study provide a framework to guide engineering of future SARS-CoV-2 vaccines.
The Montlake facility is the only U.S. hospital with seven consecutive 'Magnet' designations, representing gold-standard nursing.
Controlling when and where an immune-prompting molecule is active may make treatment safer, more effective.